Deswell Industries, Inc. (NASDAQ:DSWL - Get Free Report) saw a significant decrease in short interest in April. As of April 15th, there was short interest totaling 412 shares, a decrease of 73.7% from the March 31st total of 1,567 shares. Based on an average daily volume of 12,914 shares, the short-interest ratio is presently 0.0 days. Approximately 0.0% of the shares of the stock are sold short.
Wall Street Analyst Weigh In
Separately, Weiss Ratings reissued a "buy (b-)" rating on shares of Deswell Industries in a research note on Friday, March 27th. One investment analyst has rated the stock with a Buy rating, According to MarketBeat, the company has a consensus rating of "Buy".
Read Our Latest Report on DSWL
Deswell Industries Trading Up 0.6%
Shares of NASDAQ:DSWL traded up $0.02 on Friday, hitting $3.33. The company had a trading volume of 6,205 shares, compared to its average volume of 11,968. The company has a market cap of $53.06 million, a PE ratio of 6.94 and a beta of 0.63. Deswell Industries has a 52-week low of $1.93 and a 52-week high of $4.48. The business has a 50 day moving average of $3.33 and a 200 day moving average of $3.44.
Institutional Inflows and Outflows
A hedge fund recently bought a new stake in Deswell Industries stock. Royal Palms Capital LLC acquired a new stake in Deswell Industries, Inc. (NASDAQ:DSWL - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 460,893 shares of the technology company's stock, valued at approximately $1,595,000. Deswell Industries accounts for 1.9% of Royal Palms Capital LLC's investment portfolio, making the stock its 24th largest position. Royal Palms Capital LLC owned 2.89% of Deswell Industries as of its most recent SEC filing.
Deswell Industries Company Profile
(
Get Free Report)
Deswell Industries, Inc NASDAQ: DSWL is a China-based medical device company that designs, develops, manufactures and distributes airway management and respiratory care products. The company's product portfolio includes laryngeal mask airways, disposable endotracheal tubes, nebulizers, oxygen therapy equipment, humidifiers and related ventilator accessories. Deswell's devices are used in hospitals, clinics and home-care settings to support anesthesia, emergency medicine and respiratory treatment.
Founded in 2003 and headquartered in Shenzhen, Deswell operates multiple manufacturing facilities that comply with international quality standards, including FDA 510(k) clearances and CE markings for many of its devices.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Deswell Industries, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Deswell Industries wasn't on the list.
While Deswell Industries currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Spring 2026, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.